Chest Rub

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of cough due to the common cold when applied to the chest and throat. Additionally, it is indicated for the temporary relief of minor aches and pains when applied to muscles and joints.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, a thick layer of the product should be applied to the chest and throat, or it may be rubbed onto sore, aching muscles. If desired, the area can be covered with a warm, dry cloth to enhance the effect. It is recommended to keep clothing loose around the throat and chest to facilitate the release of vapors to the nose and mouth. This application may be repeated up to three times within a 24-hour period, or as directed by a healthcare professional.

For children under 2 years of age, it is advised to consult a doctor before use.

Contraindications

The product is contraindicated for oral administration. It should not be applied with tight bandages, in the nostrils, or on wounds or damaged skin. These restrictions are in place to prevent potential adverse effects associated with improper use.

Warnings and Precautions

For external use only; direct contact with the eyes must be avoided to prevent irritation or injury.

In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a Poison Control Center. Prompt action is crucial to ensure safety and mitigate potential risks associated with ingestion.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following occur: muscle aches and pains that persist for more than 7 days or recur, or if a cough lasts longer than 7 days, returns, or is accompanied by fever, rash, or a persistent headache. These symptoms may indicate a serious underlying condition that requires further evaluation.

Emergency medical help should be sought without delay in cases of accidental ingestion, reinforcing the importance of immediate intervention in such scenarios.

Side Effects

Patients should be aware that the product is for external use only and must avoid contact with the eyes. Failure to adhere to these warnings could result in serious consequences.

In clinical practice, patients are advised to stop using the product and consult a doctor if muscle aches and pains persist for more than 7 days or if they recur. Additionally, if a cough lasts more than 7 days, returns, or occurs alongside fever, rash, or a persistent headache, these symptoms may indicate a serious underlying condition that requires medical evaluation.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Chest Rub (camphor, eucalyptus oil, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the recommended application involves rubbing a thick layer on the chest and throat or on sore, aching muscles. It is advised to cover the area with a warm, dry cloth if desired and to keep clothing loose around the throat and chest to facilitate the release of vapors. This application may be repeated up to three times within a 24-hour period or as directed by a healthcare provider.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits associated with the use of this drug during pregnancy and lactation. Healthcare providers can offer guidance based on individual circumstances and the latest clinical data.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, and specific interventions may be required based on the symptoms presented.

Management of an overdose may involve the administration of activated charcoal if the patient presents within a suitable timeframe and is not at risk for aspiration. In cases of severe toxicity, advanced interventions such as airway management, intravenous fluids, or antidotes may be warranted, depending on the specific agent involved.

It is crucial for healthcare professionals to consult local poison control centers or toxicology experts for guidance on the management of overdose cases, as they can provide tailored recommendations based on the latest evidence and clinical protocols.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of accidental ingestion of the product. It is important to instruct patients not to use the product by mouth, and to avoid application with tight bandages, in the nostrils, or on wounds and damaged skin.

Patients should be informed to discontinue use and consult a doctor if muscle aches and pains persist for more than 7 days or if they recur. Additionally, they should be advised to stop use and seek medical advice if a cough lasts more than 7 days, returns, or occurs alongside fever, rash, or a persistent headache, as these symptoms may indicate a serious condition.

When using this product, patients must be cautioned against heating it, microwaving it, or adding it to hot water or any container that involves heating water, as this may cause splattering and result in burns. Furthermore, patients should be encouraged to consult a doctor before using the product if they have a cough accompanied by excessive phlegm (mucus) or if they experience a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

The product is administered topically. For adults and children aged 2 years and older, a thick layer should be applied to the chest and throat or on sore, aching muscles. It is recommended to cover the area with a warm, dry cloth if desired and to keep clothing loose around the throat and chest to facilitate the inhalation of vapors. This application can be repeated up to three times within a 24-hour period or as directed by a healthcare professional. For children under 2 years of age, consultation with a doctor is advised before use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Chest Rub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)